Profile of the using antihypertension pre-eclampsia patients at hospital
Keywords:
effectiveness, drug use, nifedipin, pre-eclampsiaAbstract
Pre-eclampsia was a class of hypertension in pregnancy. Based on WHO in 2015 the prevalence of preeclampsia in developed countries was around 1.3-6% while in developing countries it was around 1.8-18%. Antihypertensive therapy in pre-eclampsia patients was calcium channel blockers. Nifedipine was a dihydropyridine calcium channel blocking agent used as a first-line antihypertensive treatment for pre-eclampsia. The used of hypertension drugs in pregnancy can be said to be successful and effective when blood pressure reaches the target of <140/90 mmHg. The purposed of this study was to analyze the profile of the effectiveness of using nifedipine in pre-eclampsia patients at Hospital. This research was a quantitative research with a retrospective descriptive design. The total sample was 91 patients. The data source used medical record data from pre-eclampsia patients at Hospital in the 2022 period. The sampling used was simple random sampling technique and data was displayed in the form of frequency and percentage. The results of this studied indicate that the used of the drug nifedipine 10 mg (13%) nifedipine 3x10 mg (87%), the average blood pressure before 161.37/101.26 mmHg, the average blood pressure after 132.97/85.60 mmHg and the effectiveness of using nifedipine was 100% effective. Thus it could be concluded that the profile of the effectiveness of using nifedipine was said to be effective because it could reduce blood pressure. Nifedipine was recommended in pre-eclampsia patients to lower blood pressure
References
Alatas, Haidar (2019) Hipertensi pada Kehamilan. Herb-Medicine Journal, 27-51.
Andriana Dwi, D., Utami Dyah, E., & Sholihat Kurnia, N (2018) Evaluasi PenggunaanObat Antihipertensi pada Pasien Pre-eklampsia Rawat Inap di RSUD Prof, Dr. Margono Soekarjo Purwokerto. Acta Pharmaciae Indonesia: Acta Pharm Indo, 6(1), 29.
Danu, Indra Wardana (2020) Nutrisi untuk Mencegah Pre-Eklampsia pada Masa Kehamilan. Jember: Universitas Muhammadiyah Jember.
Dinas Kesehatan Provinsi Jawa Timur (2020) Profil Kesehatan Provinsi Jawa Timur 2020. Dinas Kesehatan Provinsi Jawa Timur., tabel 53.
Easterling, et al (2019) Oral Antihypertensive Regimens (Nifedipine retard, Labetalol, and Methyldopa) for Management of Severe Hypertension in Pregnancy: an Open Label, Randomized Controlled Trial, Lancet.
Hapsari, MMWE, dan Zulkarnaen, AK (2012) Penggunaan Obat pada Pasien Hipertensi di Instalasi Rawat Inap Rumah Sakit Dr. Kariadi Semarang. Semarang: Majalah Farmaseutik, Vol 8. No.2
Kementerian Kesehatan Republik Indonesia (2020) Profil Kesehatan Indonesia Tahun2019.Jakarta: Kementrian Kesehatan Republik Indonesia.
Nurizawati, N dan Nera, U.P (2018) Profil Penggunaan Antihipertensi Pada Pasien Pre Eklampsia Di Rumah Sakit Umum Yarsi Pontianak Tahun (2018) Analytical Biochemistry. Volume 11, Nomor 1.
Saraswati, Nuning, Mardiana & Mardiana (2016) Fakto Risiko Yang Berhubungan Dengan Kejadian Preeklampsia Pada Ibu Hamil (Studi Kasus Di Rsud Kabupaten Brebes Tahun 2014). Unnes Journal of Public Health, 5(2), 90–99.
Smith, Patricia (2000) Nifedipine in Pregnancy. British Journal of Obstetrics and Gynaecology. Vol. 107,pp.299307.
Sudarman., Tendean, H.M.M dan Wagey, F.W (2021) Faktor-faktor yang Berhubungan
dengan Terjadinya Preeklampsia. journal e-CliniC. Volume 9, Nomor 1.
Tyashapsari MWE, Zulkarnain AK.(2012) Penggunaan obat pada pasien hipertensi diinstalasi rawat inap Rumah Sakit Umum Pusat Dr. Kariadi Semarang. Maj Farmaseut. 2012;8(2):145–51. doi: 10.22146/farmaseutik.v8i2.24068.
WHO (2015) Prevention and treatment of pre-eclampsia and eclampsia. In Journal of Steroid Biochemistry & Molecular Biology (Vol. 97).
Mayasari (2020) Identifikasi Medication Error Obat Antihipertensi, CV Pena Persada
Mayasari, S (2020) Analysis Of The Used Of Captopril Drug With Blood Pressure Of Hypertension Patients. Jurnal Kesehatan Dr. Soebandi, 8(2), 123–127.
